Hello, everyone, and how are you today? We are doing reasonably well as we attempt to survive a connection issue, which explains the late arrival of your morning menu of tidbits. We apologize for the delay and are working to fix the high-tech boo-boo as quickly as possible. This calls for several cups of stimulation, of course, as we scramble to get on with the day. We hope your own adventure is smoother and that your day is as productive as can be.

The pharmaceutical industry trade group, known as PhRMA, collected $271 million in member dues and other income in 2016, up from $220 million the year before, Kaiser Health News says, citing Internal Revenue Service data.  The money was spread among hundreds of lobbyists, politicians and patient groups, as well as $7 million to prepare its ubiquitous “Go Boldly” ad campaign.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy